Jefferies Group Analysts Give Sanofi SA (SAN) a €74.00 Price Target
SAN has been the subject of a number of other reports. JPMorgan Chase & Co. reissued a sell rating on shares of Sanofi SA in a research report on Tuesday, October 4th. Kepler Capital Markets set a €89.00 ($97.80) price target on Sanofi SA and gave the company a buy rating in a report on Thursday, August 11th. Berenberg Bank set a €93.00 ($102.20) price target on Sanofi SA and gave the company a buy rating in a report on Thursday, September 8th. Societe Generale set a €100.00 ($109.89) price target on Sanofi SA and gave the company a buy rating in a report on Monday, August 1st. Finally, BNP Paribas set a €78.00 ($85.71) price target on Sanofi SA and gave the company a neutral rating in a report on Wednesday, September 14th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have issued a buy rating to the company. Sanofi SA currently has a consensus rating of Hold and a consensus target price of €86.18 ($94.70).
Shares of Sanofi SA (EPA:SAN) opened at 68.63 on Thursday. The stock’s 50 day moving average is €25.91 and its 200-day moving average is €25.76. The firm has a market cap of €88.33 billion and a PE ratio of 21.34. Sanofi SA has a 52 week low of €22.81 and a 52 week high of €68.79.
Sanofi SA Company Profile
Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.
Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.